The FDA approved the first mRNA flu vaccine for use in older adults. Here’s what to know

For older adults, the flu vaccine could look a little different this year. Last week, the US Food and Drug Administration ...
Nature

Will the mRNA flu shot work better than a regular seasonal one? What the science says

Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.

What To Know About The New, More Effective Flu Shot For Adults 50 And Over

After several disastrous flu seasons, there is some good news: The U.S. Food and Drug Administration approved a new, more ...
Smithsonian Magazine

For the First Time, an mRNA Flu Shot Will Be Available to Some People in the United States. Here’s What You Should Know

The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...

FDA approves new flu shot using COVID-era tech—here’s who can get it

The FDA tried to block it. Now the first mRNA flu shot is approved—here is who is eligible, and who is not.
The Print on MSN

1st mRNA flu vaccine gets FDA nod after rare U-turn. What the technology does & why it faced scrutiny

Moderna’s mFLUSIVA is the first mRNA vaccine approved for seasonal flu. Its route to approval was unusual, with the FDA ...
WOWO

FDA Approves First mRNA Flu Vaccine for Older Adults Ahead of 2026-27 Flu Season

Millions of older Americans will have access to a new type of influenza vaccine after the Food and Drug Administration ...
The Scientist

First mRNA Flu Shot Approved. What’s Next for mRNA Drugs?

RNA technology is moving beyond vaccines to enable targeted gene-editing therapies and novel treatments for complex diseases, ...

The new mRNA flu shot mFlusiva is more effective. Why doctors worry Long Islanders may not try it.

Although experts estimate COVID vaccines saved more than three million American lives, a survey found only 56% of Americans ...
Everyday Health

FDA Approves First mRNA Flu Vaccine for Adults 50 and Older

Vaccine makers can produce mRNA shots faster than those made with older technology, which could cut the risk of a mismatch ...